News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
731,416 Results
Type
Article (42013)
Company Profile (296)
Press Release (689093)
Multimedia
Podcasts (88)
Webinars (21)
Section
Business (205807)
Career Advice (2050)
Deals (35680)
Drug Delivery (121)
Drug Development (81704)
Employer Resources (174)
FDA (16568)
Job Trends (15041)
News (348186)
Policy (32857)
Tag
2027 BioCapital Elite (1)
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2624)
Accelerated approval (42)
Adcomms (26)
Allergies (160)
Alliances (50013)
ALS (193)
Alzheimer's disease (1752)
Antibody-drug conjugate (ADC) (372)
Approvals (16889)
Artificial intelligence (615)
Autoimmune disease (227)
Automation (52)
Bankruptcy (362)
Best Places to Work (11701)
BIOSECURE Act (20)
Biosimilars (202)
Biotechnology (201)
Bladder cancer (179)
Brain cancer (64)
Breast cancer (699)
Cancer (5369)
Cardiovascular disease (450)
Career advice (1735)
Career pathing (40)
CAR-T (304)
CDC (53)
Celiac Disease (2)
Cell therapy (805)
Cervical cancer (41)
Clinical research (70392)
Collaboration (1932)
Company closure (4)
Compensation (1267)
Complete response letters (69)
COVID-19 (2739)
CRISPR (102)
C-suite (988)
Cystic fibrosis (148)
Data (7085)
Decentralized trials (3)
Denatured (28)
Depression (156)
Dermatology (57)
Diabetes (550)
Diagnostics (6946)
Digital health (54)
Diversity (12)
Diversity, equity & inclusion (46)
Drug discovery (298)
Drug pricing (193)
Drug shortages (30)
Duchenne muscular dystrophy (266)
Earnings (91296)
Editorial (60)
Employer branding (21)
Employer resources (154)
Events (119291)
Executive appointments (1049)
FDA (20018)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (30)
Funding (1628)
Gene editing (219)
Generative AI (54)
Gene therapy (660)
GLP-1 (1023)
Government (4710)
Grass and pollen (6)
Guidances (397)
Healthcare (19099)
HIV (74)
Huntington's disease (52)
IgA nephropathy (91)
Immunology and inflammation (276)
Immuno-oncology (83)
Indications (157)
Infectious disease (3052)
Inflammatory bowel disease (203)
Inflation Reduction Act (14)
Influenza (129)
Intellectual property (278)
Interviews (320)
IPO (16698)
IRA (50)
Job creations (3661)
Job search strategy (1445)
JPM (59)
Kidney cancer (18)
Labor market (92)
Layoffs (557)
Leadership (35)
Legal (7958)
Liver cancer (99)
Longevity (28)
Lung cancer (718)
Lymphoma (408)
Machine learning (53)
Management (60)
Manufacturing (923)
MASH (179)
Medical device (13970)
Medtech (14049)
Mergers & acquisitions (20145)
Metabolic disorders (1414)
mRNA (176)
Multiple sclerosis (172)
NASH (17)
Neurodegenerative disease (389)
Neuropsychiatric disorders (98)
Neuroscience (3157)
Neurotech (1)
NextGen: Class of 2026 (6589)
Non-profit (4564)
Now hiring (73)
Obesity (665)
Opinion (278)
Ovarian cancer (186)
Pain (228)
Pancreatic cancer (254)
Parkinson's disease (342)
Partnered (33)
Patents (554)
Patient recruitment (595)
Peanut (60)
People (59583)
Pharmaceutical (62)
Pharmacy benefit managers (32)
Phase 1 (21969)
Phase 2 (30985)
Phase 3 (23066)
Pipeline (7143)
Policy (302)
Postmarket research (2568)
Preclinical (9347)
Press Release (66)
Prostate cancer (278)
Psychedelics (49)
Radiopharmaceuticals (304)
Rare diseases (995)
Real estate (5987)
Recruiting (70)
Regulatory (25081)
Reports (54)
Research institute (2458)
Resumes & cover letters (354)
Rett syndrome (32)
RNA editing (17)
RSV (85)
Schizophrenia (164)
Series A (272)
Series B (203)
Service/supplier (11)
Sickle cell disease (110)
Special edition (23)
Spinal muscular atrophy (164)
Sponsored (46)
Startups (3659)
State (2)
Stomach cancer (19)
Supply chain (119)
Tariffs (84)
The Weekly (58)
Vaccines (1058)
Venture capital (98)
Weight loss (424)
Women's health (109)
Worklife (19)
Date
Today (118)
Last 7 days (662)
Last 30 days (2746)
Last 365 days (30342)
2026 (8056)
2025 (30551)
2024 (35539)
2023 (40439)
2022 (51530)
2021 (56093)
2020 (54422)
2019 (46890)
2018 (35258)
2017 (32387)
2016 (31770)
2015 (37817)
2014 (31526)
2013 (26577)
2012 (28767)
2011 (29438)
2010 (27457)
Location
Africa (746)
Alabama (90)
Alaska (7)
Arizona (331)
Arkansas (13)
Asia (39802)
Australia (6505)
California (12376)
Canada (3516)
China (1240)
Colorado (528)
Connecticut (529)
Delaware (366)
Europe (86505)
Florida (1861)
Georgia (401)
Hawaii (3)
Idaho (62)
Illinois (960)
India (80)
Indiana (558)
Iowa (22)
Japan (489)
Kansas (131)
Kentucky (46)
Louisiana (40)
Maine (73)
Maryland (1496)
Massachusetts (8871)
Michigan (348)
Minnesota (683)
Mississippi (6)
Missouri (148)
Montana (33)
Nebraska (29)
Nevada (137)
New Hampshire (82)
New Jersey (3276)
New Mexico (29)
New York (3267)
North Carolina (1560)
North Dakota (8)
Northern California (6109)
Ohio (369)
Oklahoma (23)
Oregon (41)
Pennsylvania (2491)
Puerto Rico (27)
Rhode Island (50)
South America (1121)
South Carolina (77)
South Dakota (1)
Southern California (4865)
Tennessee (201)
Texas (1942)
United States (43816)
Utah (371)
Vermont (1)
Virginia (298)
Washington D.C. (80)
Washington State (1003)
West Virginia (4)
Wisconsin (119)
Wyoming (2)
731,416 Results for "precision biochemicals inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - April 2, 2026
April 3, 2026
·
1 min read
Press Releases
Catheter Precision, Inc. Secures up to $88 Million in Strategic Institutional Financing Commitments to Fund Accelerated Growth
March 11, 2026
·
6 min read
Press Releases
Praxis Precision Medicines, Inc. Announces Proposed Public Offering
January 7, 2026
·
4 min read
Opinion
Opinion: The Barrier to ALS Precision Drugs Isn’t Science. It’s the ‘Valley of Death’
As Congress debates renewing the Act for ALS, it must prepare for the coming era of precision ALS medicine by prioritizing early-stage research to more quickly bring effective treatments to the market.
March 19, 2026
·
5 min read
·
Bernie Zipprich
Press Releases
Catheter Precision, Inc. Secures up to $36.5 Million in Strategic Institutional Financing to Accelerate Growth
February 12, 2026
·
2 min read
Press Releases
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - March 4, 2026
March 5, 2026
·
1 min read
Sponsored
What Biopharma Can Learn from Formula 1: Precision, Speed, and the Power of the Right Partner
As the Formula 1 season kicks off in the APAC region, biopharma companies can take a page from the popular sport’s playbook around precision, adaptability, and the right team. In return, biopharma can also offer some lessons to elite motor sport on well-rounded excellence in the race to market.
March 16, 2026
·
5 min read
Press Releases
Praxis Precision Medicines, Inc. Announces Pricing of $575 Million Public Offering
January 7, 2026
·
4 min read
Press Releases
Catheter Precision Engages Strategic Advisor
April 2, 2026
·
3 min read
Press Releases
Vivos Inc. Announces Significant Progress Toward FDA Investigational Device Exemption (IDE) Submission for RadioGel® Precision Radionuclide Therapy™
February 10, 2026
·
4 min read
1 of 73,142
Next
